NO823596L - Fremgangsmaate for fremstilling av 4-(3-metyl-2-butenyl)-1,2-difenyl-3,5-dioksopyrazolidin - Google Patents

Fremgangsmaate for fremstilling av 4-(3-metyl-2-butenyl)-1,2-difenyl-3,5-dioksopyrazolidin

Info

Publication number
NO823596L
NO823596L NO823596A NO823596A NO823596L NO 823596 L NO823596 L NO 823596L NO 823596 A NO823596 A NO 823596A NO 823596 A NO823596 A NO 823596A NO 823596 L NO823596 L NO 823596L
Authority
NO
Norway
Prior art keywords
methyl
diphenyl
butenyl
dioxopyrazolidine
palladium
Prior art date
Application number
NO823596A
Other languages
English (en)
Norwegian (no)
Inventor
Arturo Donetti
Myrna Gil Quintero
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Publication of NO823596L publication Critical patent/NO823596L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32—Oxygen atoms
    • C07D231/34—Oxygen atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO823596A 1981-10-29 1982-10-28 Fremgangsmaate for fremstilling av 4-(3-metyl-2-butenyl)-1,2-difenyl-3,5-dioksopyrazolidin NO823596L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24772/81A IT1168184B (it) 1981-10-29 1981-10-29 Processo per la preparazione della 4-(3-metil-2-butanile)-1,2-difenil-3,5 dichetopirazolidina

Publications (1)

Publication Number Publication Date
NO823596L true NO823596L (no) 1983-05-02

Family

ID=11214682

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823596A NO823596L (no) 1981-10-29 1982-10-28 Fremgangsmaate for fremstilling av 4-(3-metyl-2-butenyl)-1,2-difenyl-3,5-dioksopyrazolidin

Country Status (19)

Country Link
JP (1) JPS5888365A (es)
KR (1) KR840001955A (es)
AR (1) AR231832A1 (es)
AT (1) AT379151B (es)
CA (1) CA1179354A (es)
CH (1) CH651555A5 (es)
DK (1) DK477882A (es)
ES (1) ES8308855A1 (es)
FI (1) FI823545A7 (es)
FR (1) FR2515646B1 (es)
GB (1) GB2108125B (es)
GR (1) GR77724B (es)
IT (1) IT1168184B (es)
NL (1) NL8204170A (es)
NO (1) NO823596L (es)
PH (1) PH19644A (es)
PT (1) PT75755B (es)
SE (1) SE8206143L (es)
YU (1) YU240282A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107778247A (zh) * 2016-08-30 2018-03-09 天津太平洋制药有限公司 一种非普拉宗及其中间体的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1301857A (es) * 1969-06-27 1973-01-04

Also Published As

Publication number Publication date
SE8206143D0 (sv) 1982-10-28
AT379151B (de) 1985-11-25
DK477882A (da) 1983-04-30
PH19644A (en) 1986-06-04
GB2108125A (en) 1983-05-11
CH651555A5 (de) 1985-09-30
PT75755B (en) 1985-11-20
YU240282A (en) 1985-03-20
IT8124772A0 (it) 1981-10-29
ES516902A0 (es) 1983-10-01
JPS5888365A (ja) 1983-05-26
SE8206143L (sv) 1983-04-30
AR231832A1 (es) 1985-03-29
PT75755A (en) 1982-11-01
FR2515646A1 (fr) 1983-05-06
IT8124772A1 (it) 1983-04-29
KR840001955A (ko) 1984-06-07
GR77724B (es) 1984-09-25
FI823545L (fi) 1983-04-30
ATA370382A (de) 1985-04-15
ES8308855A1 (es) 1983-10-01
CA1179354A (en) 1984-12-11
IT1168184B (it) 1987-05-20
GB2108125B (en) 1985-03-20
FR2515646B1 (fr) 1986-02-14
FI823545A7 (fi) 1983-04-30
FI823545A0 (fi) 1982-10-18
NL8204170A (nl) 1983-05-16

Similar Documents

Publication Publication Date Title
JPH022870B2 (es)
US4424390A (en) Process for producing 5-halomethylfurfural
Evans et al. The Sulfonic Acids Derived from Pyridine and 2, 6-Lutidine and the Corresponding N-Oxides1
CN115215766B (zh) 一种克立硼罗中间体的制备方法
JPS58110567A (ja) 新規４−（１−ヒドロキシル−２−〔（アシルアミノ）アルキルアミノ〕エチル）フエノ−ルのエステル、その製造法及びこれを含有する局所的消炎症性製薬組成物
NO823596L (no) Fremgangsmaate for fremstilling av 4-(3-metyl-2-butenyl)-1,2-difenyl-3,5-dioksopyrazolidin
JPS61129145A (ja) ヒドロキノン誘導体及びその製造方法
JPH0768163B2 (ja) シクロペンテノン誘導体の製法
CN113354595A (zh) 一种多取代异噁唑烷的合成方法
Ball et al. 5, 6-DIDEOXY-l-ARABINO-HEXOSE (5-DEOXY-5-C-METHYL-l-ARABINOSE)
JPS607632B2 (ja) チエノ（３，２―ｃ）ピリジン及びその誘導体の製造方法
JP2606184B2 (ja) 新規な２−ヒドロキシメチル−４−メトキシ−３，５−ジメチルピリジンの製造方法
US4096177A (en) Process for the preparation of p. isobutyl-hydratropic
JPS5928555B2 (ja) ５−アシルオキシメチルフルフラ−ルの製法
US4028369A (en) Preparation of glycol (2-(p-chlorophenoxy)-2-methylpropionate)-2-nicotinate
JPH0119371B2 (es)
JPS6357429B2 (es)
JPS59510B2 (ja) ピリジンユウドウタイ ノ セイゾウホウ
WP VOL. CXX. i. ff
JPH0161093B2 (es)
JPS6210065A (ja) ４−アシルアミノピリジン類の製造法
JPH0753702B2 (ja) アミノケトン類の分離方法
JPS63156757A (ja) ハロニトロベンゼンの製造方法
JPS6054942B2 (ja) シクロヘキサンカルボン酸誘導体の製造法
JPS62242681A (ja) ピペリジウム誘導体の４級塩の製法